Table 1 Demographics, disease characteristics and concomitant therapies of subjects (RA, PsA and control) from whom the samples were obtained
Characteristics | RA (n = 10) | PsA (n = 10) | Control (n = 10) |
|---|---|---|---|
Females (%) | 80 | 10 | 50 |
Age (years) | 55 ± 13.5 | 43 ± 12.0 | 61 ± 9.9 |
Total actively inflamed joints | NA | 1.9 ± 1.7 | – |
Swollen joint count | NA | 1.2 ± 1.2 | – |
Tender joint count | NA | 1.3 ± 1.5 | – |
With dactylitis (%) | – | 40 | – |
With enthesitis (%) | – | 0 | – |
Total clinically damaged joints | NA | 7.8 ± 11.3 | – |
On NSAIDs (%) | 10% | 60% | – |
On DMARDs (%) | 50% | 40% | – |